Difgen Pharms Company Profile
What is the competitive landscape for DIFGEN PHARMS
DIFGEN PHARMS has five approved drugs.
Summary for Difgen Pharms
| US Patents: | 0 |
| Tradenames: | 12 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Difgen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Difgen Pharms | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 212756-002 | Jun 2, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Difgen Pharms | FENTANYL-12 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 077449-005 | Sep 11, 2015 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Difgen Pharms | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 212756-003 | Feb 13, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Difgen Pharms | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210272-003 | Sep 23, 2021 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Difgen Pharms | FENTANYL-37 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 077449-006 | Dec 6, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Difgen Pharms | NICOTINE | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 074612-002 | Jul 28, 2003 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Difgen Pharms | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 212756-001 | Jun 2, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
